<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01765530</url>
  </required_header>
  <id_info>
    <org_study_id>MGH-ETT cleaning</org_study_id>
    <nct_id>NCT01765530</nct_id>
  </id_info>
  <brief_title>Efficacy Study of a Novel Device to Clean the Endotracheal Tube</brief_title>
  <official_title>Endotracheal Tubes Cleaned With a Novel Mechanism for Secretions Removal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>West Virginia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>endOclear, LLC.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the in-vivo efficacy of a novel device (endOclear)
      for cleaning the endotracheal tube (ETT) lumen from secretions. The investigators hypothesize
      that a protocol of routine ETT cleaning with endOclear may increase the ETT luminal volume
      measured at extubation compared to the current standard of care. The device may therefore be
      clinically useful by better maintaining the ETT original function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After a few days of mechanical ventilation (MV), the lumen of the endotracheal tube (ETT) is
      coated with a thick bacterial biofilm, which is a potential source for bacterial colonization
      of the lower respiratory tract and ventilator-associated pneumonia (VAP). Accumulation of
      mucus/secretions on the interior of the ETT also effectively lowers the cross section of the
      ETT and increases significantly the work of breathing in intubated patients, who then require
      increased MV support, with prolonged intubation and ICU stay.

      A primary goal for all ICUs is to shorten the time of MV, to decrease the incidence of ETT
      microbial colonization and ultimately VAP incidence. To meet this goal several airways
      technologies to maintain the ETT free from debris/bacteria have been developed in order to
      improve the current ventilator-liberation standards in intubated critically ill patients.

      Based on preliminary laboratory, animal and clinical data, The investigators now wish to test
      the hypothesis that a novel commercially available ETT cleaning device can be effective in
      targeting two specific issues:

        -  Specific aim 1: To evaluate the mean difference in ETT luminal volume of ETTs cleaned
           with the novel cleaning device (EndOclear) vs. ETT cleaned in the standard manner.

        -  Specific aim 2: To determine whether ETTs cleaned with the novel device show a lower
           degree of microbial colonization for the entire period of mechanical ventilation.

      Data about in-vivo respiratory mechanics measurements, microbial diversity and antibiotic
      resistance analysis, users' feedbacks and safety of the device will also be collected.

      The investigators will conduct a clinical trial on 74 intubated patients randomized to
      receive standard ETT cleaning or cleaning with the EndOclear.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Occlusion Assessed Using a High Definition Computed Tomography Imaging of the Extubated ETTs</measure>
    <time_frame>At extubation (An expected average of 5 days)</time_frame>
    <description>The investigators will measure percentage of occlusion determined by the accumulation of secretion within the lumen of each ETT using a high definition Computed Tomography (CT) imaging of the extubated ETTs. The whole ETT will be analyzed through high-definition CT slices. 100% of occlusion means total occlusion of the lumen of the ETT and 0% means absence of any occlusion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ETT Microbiology</measure>
    <time_frame>At extubation (An expected average of 5 days)</time_frame>
    <description>For each patient a quantitative culture will be obtained from the ETT after extubation. Secretions will be retrieved from the ETT after CT scan and quantitative standard cultures will be performed. Microbial molecular diversity analysis and antibacterial resistance patterns will also be studied.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Endotracheal Extubation</condition>
  <condition>Airway Obstruction</condition>
  <condition>Airway Control</condition>
  <condition>Pneumonia, Ventilator-Associated</condition>
  <condition>Breathing Mechanics</condition>
  <arm_group>
    <arm_group_label>ETT cleaning manuver</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to the treatment group will undergo an ETT cleaning maneuver with endOclear three times a day (every 8 hours) for the whole intubation period in addition to the standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In the protocol no intervention is planned for the control group, which will therefore be treated with blind suctioning as per caregiver clinical decision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ETT cleaning maneuver</intervention_name>
    <description>EndOclear device will be used for ETT cleaning maneuver. This is a commercially available device. It consists of an ETT cleaning apparatus with a flexible central tube and a cleaning device at its distal end. The cleaning device has a mechanically expandable mesh structure which can be adapted to selectively move between a radially-collapsed position and a radially-expanded one. In operation, the collapsed cleaning apparatus is inserted into the ETT through a Y-shaped connector. The device is then expanded by a safety toggle protected trigger mechanism that, when fired, presses the device's smooth silicone disc against the inside surface of the ETT. The cleaning apparatus is then pulled out of the ETT removing mucus deposits and secretions.
We will add endOclear to the standard ICU practice, scheduling the systematic use of the device every 8 hours for the whole intubation period.</description>
    <arm_group_label>ETT cleaning manuver</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Patients expected to be intubated for at least 48 hours or longer

          -  Enrollment within 24 hours from intubation time

        Exclusion Criteria:

          -  Current and past participation in another intervention trial conflicting with the
             present study

          -  Pregnant women and prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert M Kacmarek, PhD, RRT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Adair CG, Gorman SP, Feron BM, Byers LM, Jones DS, Goldsmith CE, Moore JE, Kerr JR, Curran MD, Hogg G, Webb CH, McCarthy GJ, Milligan KR. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med. 1999 Oct;25(10):1072-6.</citation>
    <PMID>10551961</PMID>
  </reference>
  <reference>
    <citation>Shapiro M, Wilson RK, Casar G, Bloom K, Teague RB. Work of breathing through different sized endotracheal tubes. Crit Care Med. 1986 Dec;14(12):1028-31.</citation>
    <PMID>3780244</PMID>
  </reference>
  <reference>
    <citation>Heyer L, Louis B, Isabey D, Lofaso F, Brochard L, Fredberg JJ, Harf A. Noninvasive estimate of work of breathing due to the endotracheal tube. Anesthesiology. 1996 Dec;85(6):1324-33.</citation>
    <PMID>8968179</PMID>
  </reference>
  <reference>
    <citation>Glass C, Grap MJ, Sessler CN. Endotracheal tube narrowing after closed-system suctioning: prevalence and risk factors. Am J Crit Care. 1999 Mar;8(2):93-100.</citation>
    <PMID>10071699</PMID>
  </reference>
  <reference>
    <citation>Shah C, Kollef MH. Endotracheal tube intraluminal volume loss among mechanically ventilated patients. Crit Care Med. 2004 Jan;32(1):120-5.</citation>
    <PMID>14707569</PMID>
  </reference>
  <reference>
    <citation>Boqué MC, Gualis B, Sandiumenge A, Rello J. Endotracheal tube intraluminal diameter narrowing after mechanical ventilation: use of acoustic reflectometry. Intensive Care Med. 2004 Dec;30(12):2204-9. Epub 2004 Oct 2.</citation>
    <PMID>15580475</PMID>
  </reference>
  <reference>
    <citation>Villafane MC, Cinnella G, Lofaso F, Isabey D, Harf A, Lemaire F, Brochard L. Gradual reduction of endotracheal tube diameter during mechanical ventilation via different humidification devices. Anesthesiology. 1996 Dec;85(6):1341-9.</citation>
    <PMID>8968181</PMID>
  </reference>
  <reference>
    <citation>Berra L, Coppadoro A, Bittner EA, Kolobow T, Laquerriere P, Pohlmann JR, Bramati S, Moss J, Pesenti A. A clinical assessment of the Mucus Shaver: a device to keep the endotracheal tube free from secretions. Crit Care Med. 2012 Jan;40(1):119-24. doi: 10.1097/CCM.0b013e31822e9fe3.</citation>
    <PMID>21926595</PMID>
  </reference>
  <reference>
    <citation>Stone RH, Bricknell SS. Experience with a new device for clearing mucus from the endotracheal tube. Respir Care. 2011 Apr;56(4):520-2. doi: 10.4187/respcare.00642. Epub 2011 Jan 21.</citation>
    <PMID>21255488</PMID>
  </reference>
  <reference>
    <citation>Inglis TJ, Millar MR, Jones JG, Robinson DA. Tracheal tube biofilm as a source of bacterial colonization of the lung. J Clin Microbiol. 1989 Sep;27(9):2014-8.</citation>
    <PMID>2778064</PMID>
  </reference>
  <reference>
    <citation>Wilson AM, Gray DM, Thomas JG. Increases in endotracheal tube resistance are unpredictable relative to duration of intubation. Chest. 2009 Oct;136(4):1006-1013. doi: 10.1378/chest.08-1938. Epub 2009 May 1.</citation>
    <PMID>19411293</PMID>
  </reference>
  <reference>
    <citation>Berra L, Curto F, Li Bassi G, Laquerriere P, Baccarelli A, Kolobow T. Antibacterial-coated tracheal tubes cleaned with the Mucus Shaver : a novel method to retain long-term bactericidal activity of coated tracheal tubes. Intensive Care Med. 2006 Jun;32(6):888-93. Epub 2006 Apr 19.</citation>
    <PMID>16601964</PMID>
  </reference>
  <reference>
    <citation>Kolobow T, Berra L, Li Bassi G, Curto F. Novel system for complete removal of secretions within the endotracheal tube: the Mucus Shaver. Anesthesiology. 2005 May;102(5):1063-5.</citation>
    <PMID>15851896</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2012</study_first_submitted>
  <study_first_submitted_qc>January 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2013</study_first_posted>
  <results_first_submitted>October 26, 2016</results_first_submitted>
  <results_first_submitted_qc>February 8, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">March 29, 2017</results_first_posted>
  <last_update_submitted>September 18, 2017</last_update_submitted>
  <last_update_submitted_qc>September 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Robert M. Kacmarek</investigator_full_name>
    <investigator_title>Director, Respiratory Care Services; Professor of Anesthesia</investigator_title>
  </responsible_party>
  <keyword>Medical Devices</keyword>
  <keyword>Ventilator-Associated Pneumonia (VAP)</keyword>
  <keyword>Ventilator-Associated Events (VAE)</keyword>
  <keyword>Endotracheal Tube</keyword>
  <keyword>Microbial Diversity</keyword>
  <keyword>Anti-Resistance</keyword>
  <keyword>Computed Tomography (CT)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Airway Obstruction</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ETT Cleaning Manuver</title>
          <description>Patients randomized to the treatment group will undergo an ETT cleaning maneuver with endOclear three times a day (every 8 hours) for the whole intubation period in addition to the standard of care.</description>
        </group>
        <group group_id="P2">
          <title>Standard of Care</title>
          <description>In the protocol no intervention is planned for the control group, which will therefore be treated with blind suctioning as per caregiver clinical decision.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ETT Cleaning Manuver</title>
          <description>Patients randomized to the treatment group will undergo an ETT cleaning maneuver with endOclear three times a day (every 8 hours) for the whole intubation period in addition to the standard of care.</description>
        </group>
        <group group_id="B2">
          <title>Standard of Care</title>
          <description>In the protocol no intervention is planned for the control group, which will therefore be treated with blind suctioning as per caregiver clinical decision.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="36"/>
            <count group_id="B3" value="72"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59" spread="19"/>
                    <measurement group_id="B2" value="64" spread="17"/>
                    <measurement group_id="B3" value="62" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Occlusion Assessed Using a High Definition Computed Tomography Imaging of the Extubated ETTs</title>
        <description>The investigators will measure percentage of occlusion determined by the accumulation of secretion within the lumen of each ETT using a high definition Computed Tomography (CT) imaging of the extubated ETTs. The whole ETT will be analyzed through high-definition CT slices. 100% of occlusion means total occlusion of the lumen of the ETT and 0% means absence of any occlusion.</description>
        <time_frame>At extubation (An expected average of 5 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ETT Cleaning Manuver</title>
            <description>Patients randomized to the treatment group will undergo an ETT cleaning maneuver with endOclear three times a day (every 8 hours) for the whole intubation period in addition to the standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>In the protocol no intervention is planned for the control group, which will therefore be treated with blind suctioning as per caregiver clinical decision.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Occlusion Assessed Using a High Definition Computed Tomography Imaging of the Extubated ETTs</title>
          <description>The investigators will measure percentage of occlusion determined by the accumulation of secretion within the lumen of each ETT using a high definition Computed Tomography (CT) imaging of the extubated ETTs. The whole ETT will be analyzed through high-definition CT slices. 100% of occlusion means total occlusion of the lumen of the ETT and 0% means absence of any occlusion.</description>
          <units>percentage of occlusion</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.6" spread="8.0"/>
                    <measurement group_id="O2" value="17.7" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ETT Microbiology</title>
        <description>For each patient a quantitative culture will be obtained from the ETT after extubation. Secretions will be retrieved from the ETT after CT scan and quantitative standard cultures will be performed. Microbial molecular diversity analysis and antibacterial resistance patterns will also be studied.</description>
        <time_frame>At extubation (An expected average of 5 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ETT Cleaning Manuver</title>
            <description>Patients randomized to the treatment group will undergo an ETT cleaning maneuver with endOclear three times a day (every 8 hours) for the whole intubation period in addition to the standard of care.</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>In the protocol no intervention is planned for the control group, which will therefore be treated with blind suctioning as per caregiver clinical decision.</description>
          </group>
        </group_list>
        <measure>
          <title>ETT Microbiology</title>
          <description>For each patient a quantitative culture will be obtained from the ETT after extubation. Secretions will be retrieved from the ETT after CT scan and quantitative standard cultures will be performed. Microbial molecular diversity analysis and antibacterial resistance patterns will also be studied.</description>
          <units>Log colony form unit (CFU)/ mL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.89" spread="0.49"/>
                    <measurement group_id="O2" value="3.35" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Entire study 6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ETT Cleaning Manuver</title>
          <description>Patients randomized to the treatment group will undergo an ETT cleaning maneuver with endOclear three times a day (every 8 hours) for the whole intubation period in addition to the standard of care.</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care</title>
          <description>In the protocol no intervention is planned for the control group, which will therefore be treated with blind suctioning as per caregiver clinical decision.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert M Kacmarek PhD, RRT</name_or_title>
      <organization>Massachusetts General Hospital</organization>
      <phone>617-724-4490</phone>
      <email>rkacmarek@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

